Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 Dimethylation

BackgroundIschemic preconditioning (IPC) protects the heart from prolonged ischemic insult and reperfusion injury through a poorly understood mechanism. Post‐translational modifications of histone residues can confer rapid and drastic switches in gene expression in response to various stimuli, inclu...

Full description

Bibliographic Details
Main Authors: Olof Gidlöf, Andrea L. Johnstone, Kerstin Bader, Bohdan B. Khomtchouk, Jiaqi J. O'Reilly, Selvi Celik, Derek J. Van Booven, Claes Wahlestedt, Bernhard Metzler, David Erlinge
Format: Article
Language:English
Published: Wiley 2016-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004076
_version_ 1819178662473236480
author Olof Gidlöf
Andrea L. Johnstone
Kerstin Bader
Bohdan B. Khomtchouk
Jiaqi J. O'Reilly
Selvi Celik
Derek J. Van Booven
Claes Wahlestedt
Bernhard Metzler
David Erlinge
author_facet Olof Gidlöf
Andrea L. Johnstone
Kerstin Bader
Bohdan B. Khomtchouk
Jiaqi J. O'Reilly
Selvi Celik
Derek J. Van Booven
Claes Wahlestedt
Bernhard Metzler
David Erlinge
author_sort Olof Gidlöf
collection DOAJ
description BackgroundIschemic preconditioning (IPC) protects the heart from prolonged ischemic insult and reperfusion injury through a poorly understood mechanism. Post‐translational modifications of histone residues can confer rapid and drastic switches in gene expression in response to various stimuli, including ischemia. The aim of this study was to investigate the effect of histone methylation in the response to cardiac ischemic preconditioning. Methods and ResultsWe used cardiac biopsies from mice subjected to IPC to quantify global levels of 3 of the most well‐studied histone methylation marks (H3K9me2, H3K27me3, and H3K4me3) with Western blot and found that H3K9me2 levels were significantly increased in the area at risk compared to remote myocardium. In order to assess which genes were affected by the increase in H3K9me2 levels, we performed ChIP‐Seq and transcriptome profiling using microarray. Two hundred thirty‐seven genes were both transcriptionally repressed and enriched in H3K9me2 in the area at risk of IPC mice. Of these, Mtor (Mechanistic target of rapamycin) was chosen for mechanistic studies. Knockdown of the major H3K9 methyltransferase G9a resulted in a significant decrease in H3K9me2 levels across Mtor, increased Mtor expression, as well as decreased autophagic activity in response to rapamycin and serum starvation. ConclusionsIPC confers an increase of H3K9me2 levels throughout the Mtor gene—a master regulator of cellular metabolism and a key player in the cardioprotective effect of IPC—leading to transcriptional repression via the methyltransferase G9a. The results of this study indicate that G9a has an important role in regulating cardiac autophagy and the cardioprotective effect of IPC.
first_indexed 2024-12-22T21:46:07Z
format Article
id doaj.art-ac44d4ee7c3e48728a41c0b1940b60c4
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-22T21:46:07Z
publishDate 2016-12-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-ac44d4ee7c3e48728a41c0b1940b60c42022-12-21T18:11:29ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802016-12-0151210.1161/JAHA.116.004076Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 DimethylationOlof Gidlöf0Andrea L. Johnstone1Kerstin Bader2Bohdan B. Khomtchouk3Jiaqi J. O'Reilly4Selvi Celik5Derek J. Van Booven6Claes Wahlestedt7Bernhard Metzler8David Erlinge9Department of Cardiology, Clinical Sciences, Lund University, Lund, SwedenThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FLDepartment of Internal Medicine III/Cardiology, Innsbruck Medical University, Innsbruck, AustriaThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FLThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FLDepartment of Cardiology, Clinical Sciences, Lund University, Lund, SwedenJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FLThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FLDepartment of Internal Medicine III/Cardiology, Innsbruck Medical University, Innsbruck, AustriaDepartment of Cardiology, Clinical Sciences, Lund University, Lund, SwedenBackgroundIschemic preconditioning (IPC) protects the heart from prolonged ischemic insult and reperfusion injury through a poorly understood mechanism. Post‐translational modifications of histone residues can confer rapid and drastic switches in gene expression in response to various stimuli, including ischemia. The aim of this study was to investigate the effect of histone methylation in the response to cardiac ischemic preconditioning. Methods and ResultsWe used cardiac biopsies from mice subjected to IPC to quantify global levels of 3 of the most well‐studied histone methylation marks (H3K9me2, H3K27me3, and H3K4me3) with Western blot and found that H3K9me2 levels were significantly increased in the area at risk compared to remote myocardium. In order to assess which genes were affected by the increase in H3K9me2 levels, we performed ChIP‐Seq and transcriptome profiling using microarray. Two hundred thirty‐seven genes were both transcriptionally repressed and enriched in H3K9me2 in the area at risk of IPC mice. Of these, Mtor (Mechanistic target of rapamycin) was chosen for mechanistic studies. Knockdown of the major H3K9 methyltransferase G9a resulted in a significant decrease in H3K9me2 levels across Mtor, increased Mtor expression, as well as decreased autophagic activity in response to rapamycin and serum starvation. ConclusionsIPC confers an increase of H3K9me2 levels throughout the Mtor gene—a master regulator of cellular metabolism and a key player in the cardioprotective effect of IPC—leading to transcriptional repression via the methyltransferase G9a. The results of this study indicate that G9a has an important role in regulating cardiac autophagy and the cardioprotective effect of IPC.https://www.ahajournals.org/doi/10.1161/JAHA.116.004076autophagyepigeneticsischemia
spellingShingle Olof Gidlöf
Andrea L. Johnstone
Kerstin Bader
Bohdan B. Khomtchouk
Jiaqi J. O'Reilly
Selvi Celik
Derek J. Van Booven
Claes Wahlestedt
Bernhard Metzler
David Erlinge
Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 Dimethylation
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
autophagy
epigenetics
ischemia
title Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 Dimethylation
title_full Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 Dimethylation
title_fullStr Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 Dimethylation
title_full_unstemmed Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 Dimethylation
title_short Ischemic Preconditioning Confers Epigenetic Repression of Mtor and Induction of Autophagy Through G9a‐Dependent H3K9 Dimethylation
title_sort ischemic preconditioning confers epigenetic repression of mtor and induction of autophagy through g9a dependent h3k9 dimethylation
topic autophagy
epigenetics
ischemia
url https://www.ahajournals.org/doi/10.1161/JAHA.116.004076
work_keys_str_mv AT olofgidlof ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT andrealjohnstone ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT kerstinbader ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT bohdanbkhomtchouk ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT jiaqijoreilly ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT selvicelik ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT derekjvanbooven ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT claeswahlestedt ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT bernhardmetzler ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation
AT daviderlinge ischemicpreconditioningconfersepigeneticrepressionofmtorandinductionofautophagythroughg9adependenth3k9dimethylation